Tigenix NV - Company & Market Research Reports

TiGenix is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic, or donor-derived, expanded stem cells. Two products from its adipose-derived stem cell technology platform are currently in clinical development. The company was formerly known as OrthoMimetics Limited and changed its name to TiGenix Limited in February, 2010. TiGenix was incorporated in 2005 and is based in Cambridge, United Kingdom.

From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator
adroll